Serum S-100 has prognostic significance in malignant melanoma.
Pretreatment serum values of S-100 and NSE were compared in patients with malignant melanoma. Pretreatment serum levels of patients with malignant melanoma were analysed for stage of disease and survival. S-100 pretreatment serum values seem highly specific, but have low sensitivity. Further evaluation is needed with an assay with improved sensitivity.